Ahead of its summer recess, the US Senate on Thursday followed its House counterparts and passed a bipartisan bill to reauthorize the US Food and Drug Administration (FDA) user fee programs for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results